LamivudineTabletsReverse Transcriptase InhibitorsHepatitis B, ChronicTablets, Enteric-CoatedOrganophosphonatesHepatitis B virusAntiviral AgentsHepatitis B e AntigensAdenineAnti-HIV AgentsDrug Resistance, ViralZidovudineStavudineCullin ProteinsHepatitis BChemistry, PharmaceuticalDideoxynucleosidesDrug Therapy, CombinationExcipientsNevirapineHIV InfectionsDrug CompoundingDNA, ViralAlanine TransaminaseBenzoxazinesDelayed-Action PreparationsHepatitis B Surface AntigensViral LoadTechnology, PharmaceuticalDidanosineIndinavirMethylcelluloseHIV-1Therapeutic EquivalencyPyrimidinonesTreatment OutcomePowdersNucleosidesOxazinesDrug Resistance, Multiple, ViralMutationAdministration, OralSKP Cullin F-Box Protein LigasesHepatitis B AntibodiesAntiretroviral Therapy, Highly ActiveGene Products, polSolubilityLopinavirTreatment FailureNelfinavirZalcitabineHardnessRitonavirGuanineHIV Reverse TranscriptaseCD4 Lymphocyte CountLiver TransplantationDrug CombinationsInterferon-alphaRecurrenceDouble-Blind MethodDideoxynucleotidesDrug Administration ScheduleHIV Protease InhibitorsDrug StabilityLubricantsArea Under CurveHepatitis B Core AntigensDosage FormsCapsulesLiver CirrhosisRNA, ViralVirus ActivationCytidine TriphosphateArabinofuranosyluracilImmunoglobulinsInfectious Disease Transmission, VerticalCellulosePovidoneCross-Over StudiesPolyethylene Glycols2-AminopurineBiological AvailabilityHardness TestsAdministration, BuccalTime FactorsF-Box ProteinsAnti-Retroviral AgentsPeptide SynthasesDrug Resistance, MicrobialCarrier Proteins